1vrw: Difference between revisions
New page: left|200px<br /><applet load="1vrw" size="450" color="white" frame="true" align="right" spinBox="true" caption="1vrw, resolution 2.40Å" /> '''Crystal structure an... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1vrw.gif|left|200px]]<br /><applet load="1vrw" size=" | [[Image:1vrw.gif|left|200px]]<br /><applet load="1vrw" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="1vrw, resolution 2.40Å" /> | caption="1vrw, resolution 2.40Å" /> | ||
'''Crystal structure analysis of plasmodium falciparum enoyl-acyl-carrier-protein reductase with nadh'''<br /> | '''Crystal structure analysis of plasmodium falciparum enoyl-acyl-carrier-protein reductase with nadh'''<br /> | ||
==Overview== | ==Overview== | ||
The human malaria parasite Plasmodium falciparum synthesizes fatty acids | The human malaria parasite Plasmodium falciparum synthesizes fatty acids using a type II pathway that is absent in humans. The final step in fatty acid elongation is catalyzed by enoyl acyl carrier protein reductase, a validated antimicrobial drug target. Here, we report the cloning and expression of the P. falciparum enoyl acyl carrier protein reductase gene, which encodes a 50-kDa protein (PfENR) predicted to target to the unique parasite apicoplast. Purified PfENR was crystallized, and its structure resolved as a binary complex with NADH, a ternary complex with triclosan and NAD(+), and as ternary complexes bound to the triclosan analogs 1 and 2 with NADH. Novel structural features were identified in the PfENR binding loop region that most closely resembled bacterial homologs; elsewhere the protein was similar to ENR from the plant Brassica napus (root mean square for Calphas, 0.30 A). Triclosan and its analogs 1 and 2 killed multidrug-resistant strains of intra-erythrocytic P. falciparum parasites at sub to low micromolar concentrations in vitro. These data define the structural basis of triclosan binding to PfENR and will facilitate structure-based optimization of PfENR inhibitors. | ||
==About this Structure== | ==About this Structure== | ||
1VRW is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Plasmodium_falciparum Plasmodium falciparum] with NAD as [http://en.wikipedia.org/wiki/ligand ligand]. This structure | 1VRW is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Plasmodium_falciparum Plasmodium falciparum] with <scene name='pdbligand=NAD:'>NAD</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. This structure supersedes the now removed PDB entry 1NHD. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1VRW OCA]. | ||
==Reference== | ==Reference== | ||
Line 15: | Line 15: | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Bittman, R.]] | [[Category: Bittman, R.]] | ||
[[Category: Fidock, D | [[Category: Fidock, D A.]] | ||
[[Category: Jr., W | [[Category: Jr., W R.Jacobs.]] | ||
[[Category: Kuo, M.]] | [[Category: Kuo, M.]] | ||
[[Category: Perozzo, R.]] | [[Category: Perozzo, R.]] | ||
[[Category: Sacchettini, J | [[Category: Sacchettini, J C.]] | ||
[[Category: Sidhu, A | [[Category: Sidhu, A S.]] | ||
[[Category: Valiyaveettil, J | [[Category: Valiyaveettil, J T.]] | ||
[[Category: NAD]] | [[Category: NAD]] | ||
[[Category: nadh]] | [[Category: nadh]] | ||
Line 27: | Line 27: | ||
[[Category: short chain dehydrogenase reductase]] | [[Category: short chain dehydrogenase reductase]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:38:00 2008'' |